Rep. Chris Collins, the New York congressman who tirelessly promoted an Australian biotech company and who now faces charges of insider trading related to the firm, prevailed in his re-election bid on Tuesday.
Collins, who has denied the allegations, prevailed over Democrat Nathan McMurray. McMurray conceded the race late Tuesday night but called for a recall early Wednesday morning, after multiple media outlets had long since called the contest in favor of Collins.
Collins’ district, New York’s 27th, is among the state’s deepest red, where President Trump won by more than 24 percent in 2016. The congressman won his last two re-elections by more than 40 percentage points and was expected to coast this year. But his yearslong relationship with Innate Immunotherapeutics put his seat up for grabs.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
